A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 15,986 shares of ABBV stock, worth $2.86 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
15,986
Previous 15,959 0.17%
Holding current value
$2.86 Million
Previous $2.74 Million 15.31%
% of portfolio
0.66%
Previous 0.63%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $4,423 - $5,381
27 Added 0.17%
15,986 $3.16 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.01%
15,959 $2.74 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $70,001 - $79,759
-438 Reduced 2.67%
15,958 $2.91 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $16,924 - $19,061
-123 Reduced 0.74%
16,396 $2.54 Million
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $51,031 - $59,076
382 Added 2.37%
16,519 $2.46 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $53,136 - $66,124
401 Added 2.55%
16,137 $2.17 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $1,446 - $1,665
10 Added 0.06%
15,736 $2.51 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $78,006 - $93,550
-564 Reduced 3.46%
15,726 $2.54 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $84,283 - $96,668
628 Added 4.01%
16,290 $2.19 Million
Q2 2022

Nov 18, 2022

SELL
$137.62 - $174.96 $86,425 - $109,874
-628 Reduced 3.86%
15,662 $2.4 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $84,773 - $107,775
-616 Reduced 3.78%
15,662 $2.4 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $4,619 - $5,731
-35 Reduced 0.21%
16,278 $2.64 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $7,627 - $9,651
71 Added 0.44%
16,313 $2.21 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $21,386 - $24,276
201 Added 1.25%
16,242 $1.75 Million
Q2 2021

Nov 08, 2021

BUY
$105.21 - $117.21 $7,469 - $8,321
71 Added 0.44%
16,041 $1.81 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $946 - $1,054
9 Added 0.06%
15,970 $1.8 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $27,927 - $30,745
273 Added 1.74%
15,961 $1.73 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $24,307 - $32,818
302 Added 1.96%
15,688 $1.68 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $2,233 - $2,621
26 Added 0.17%
15,386 $1.35 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $343,738 - $459,973
4,685 Added 43.89%
15,360 $1.51 Million
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $17,479 - $26,501
271 Added 2.6%
10,675 $813,000
Q4 2019

Jan 08, 2020

SELL
$72.13 - $90.25 $35,127 - $43,951
-487 Reduced 4.47%
10,404 $922,000
Q3 2019

Oct 08, 2019

BUY
$62.98 - $75.72 $62 - $75
1 Added 0.01%
10,891 $825,000
Q2 2019

Jul 09, 2019

BUY
$65.7 - $83.98 $11,563 - $14,780
176 Added 1.64%
10,890 $792,000
Q1 2019

Apr 11, 2019

BUY
$77.14 - $90.79 $14,270 - $16,796
185 Added 1.76%
10,714 $864,000
Q4 2018

Jan 10, 2019

BUY
$77.85 - $96.01 $77 - $96
1 Added 0.01%
10,529 $971,000
Q3 2018

Oct 09, 2018

BUY
$88.91 - $98.84 $1,333 - $1,482
15 Added 0.14%
10,528 $996,000
Q2 2018

Jul 13, 2018

BUY
$89.78 - $106.23 $8,978 - $10,623
100 Added 0.96%
10,513 $974,000
Q1 2018

Apr 16, 2018

SELL
$92.01 - $123.21 $19,046 - $25,504
-207 Reduced 1.95%
10,413 $985,000
Q4 2017

Jan 12, 2018

BUY
$89.56 - $98.21 $17,285 - $18,954
193 Added 1.85%
10,620 $1.03 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $728,325 - $930,296
10,427
10,427 $926,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.